Officer and Director Stock Transactions

2026-04-10SEC Filing 4 (0001493152-26-016166)

Tyler Korman, Chief Scientific Officer of EXOZYMES INC. (EXOZ), reported the sale of 750 shares of common stock on April 8, 2026, at a price of $10.0406 per share, resulting in 729,873 shares held post-transaction. On April 9, 2026, Korman sold an additional 750 shares at $10.525 per share, leaving him with 729,123 shares. These transactions were reported on SEC Form 4.